IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, M.
Right arrow Articles by Streilein, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, M.
Right arrow Articles by Streilein, W.
(Investigative Ophthalmology and Visual Science. 2000;41:811-821.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact

Munenori Yoshida1, Masaru Takeuchi1 and Wayne Streilein1

1 From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

PURPOSE. To determine by what mechanism(s) iris and ciliary body (I/CB) pigment epithelial (PE) cells inhibit T-cell activation in vitro.

METHODS. Pure cultured I/CB PE cells were obtained from eyes of normal and CD95 ligand (CD95L)-deficient mice and tested for their capacity to suppress T-cell activation in three different T-cell receptor (Tcr) ligand systems: mixed lymphocyte reactions, stimulation of Tcr transgenic T cells (D011.10) by specific antigen (ovalbumin), and ligation of the Tcr-associated CD3 molecule by anti-CD3 antibodies. Proliferation and secretion of cytokines (interferon [IFN]-{gamma}, interleukin [IL]-2, IL-4, and IL-10) were assessed as measures of T-cell activation. Suppressive influences of I/CB PE cells were determined on the basis of RT-PCR–detected cytokine genes expressed by I/CB PE cells, immunosuppression mediated by supernatants of cultured I/CB PE cells, direct contact between I/CB PE cells and T lymphocytes, and promotion of apoptosis among responding T cells. Attempts to reverse I/CB PE–dependent suppression of T-cell activation included the use of neutralizing antibodies to IL-10, tumor necrosis factor (TNF)-{alpha} and transforming growth factor (TGF)-ß, and the addition of exogenous IL-2 and IL-12.

RESULTS. Cultured mouse I/CB PE cells (including CD95L-deficient cells), which were more than 95% keratin positive, suppressed T-cell proliferation and secretion of IFN-{gamma}, IL-2, IL-4, and IL-10 in a dose-dependent fashion in all three Tcr ligand systems. Supernatants of cultured I/CB PE cells displayed little suppression activity, whereas cultures in which I/CB PE cells contacted responding T cells directly were profoundly immunosuppressive. Cultured I/CB PE cells expressed mRNA for TGF-ß1, TGF-ß2, IL-6, IL-10, and TNF-{alpha}, but not IL-4, IFN-{gamma}, proopiomelanocortin (POMC), and CD95L (Fas L). Antibodies to TGF-ß, IL-10, and TNF-{alpha} failed to reverse suppression mediated by I/CB PE cells. Moreover, neither exogenous IL-2 or IL-12 relieved the suppression.

CONCLUSIONS. Cultured I/CB PE cells, through direct cell-to-cell contact, prevent T cells from proliferating and secreting cytokines when stimulated through the Tcr for antigen by a mechanism that does not involve CD95 or apoptosis.




This article has been cited by other articles:


Home page
IOVSHome page
H. Sawada, T. Fukuchi, T. Tanaka, and H. Abe
Tumor Necrosis Factor-{alpha} Concentrations in the Aqueous Humor of Patients with Glaucoma
Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 903 - 906.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. L. Vega, H. Keino, and S. Masli
Surgical Denervation of Ocular Sympathetic Afferents Decreases Local Transforming Growth Factor-{beta} and Abolishes Immune Privilege
Am. J. Pathol., September 1, 2009; 175(3): 1218 - 1225.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Sugita, H. Takase, C. Taguchi, and M. Mochizuki
The Role of Soluble TNF Receptors for TNF-{alpha} in Uveitis
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3246 - 3252.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Stein-Streilein and A. W. Taylor
An eye's view of T regulatory cells
J. Leukoc. Biol., March 1, 2007; 81(3): 593 - 598.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. M. Carrington, J. Albon, I. Anderson, C. Kamma, and M. Boulton
Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-{beta} Isoforms and Their Inhibitors
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1886 - 1894.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sugita, T. F. Ng, P. J. Lucas, R. E. Gress, and J. W. Streilein
B7+ Iris Pigment Epithelium Induce CD8+ T Regulatory Cells; Both Suppress CTLA-4+ T Cells
J. Immunol., January 1, 2006; 176(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Kitaichi, K. Namba, and A. W. Taylor
Inducible immune regulation following autoimmune disease in the immune-privileged eye
J. Leukoc. Biol., April 1, 2005; 77(4): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. S. Gregerson, T. N. Sam, and S. W. McPherson
The Antigen-Presenting Activity of Fresh, Adult Parenchymal Microglia and Perivascular Cells from Retina
J. Immunol., June 1, 2004; 172(11): 6587 - 6597.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sugita, T. F. Ng, J. Schwartzkopff, and J. W. Streilein
CTLA-4+CD8+ T Cells That Encounter B7-2+ Iris Pigment Epithelial Cells Express Their Own B7-2 to Achieve Global Suppression of T Cell Activation
J. Immunol., April 1, 2004; 172(7): 4184 - 4194.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. W. Streilein
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Sugita and J. W. Streilein
Iris Pigment Epithelium Expressing CD86 (B7-2) Directly Suppresses T Cell Activation In Vitro via Binding to Cytotoxic T Lymphocyte-associated Antigen 4
J. Exp. Med., July 7, 2003; 198(1): 161 - 171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology